跳至主要内容
临床试验/ACTRN12624001187538
ACTRN12624001187538尚未招募Unknown

Transoesophageal echocardiography (TOE) in the early assessment of shocked trauma: A pilot study of a novel disposable miniaturised TOE device in the first hour of resuscitation.

Associate Professor Christopher Groombridge0 个研究点目标入组 10 人开始时间: 2024年9月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
10
主要终点
This is a feasibility study, assessing the clinicians ability to assess shock using the device. The primary outcome is the collapsibility index of the superior vena cava (two measurements of the maximum and minimum width of the SVC) as a validated marker of hypovolaemia. This will be reported as the proportion of patients where clinicians are able to achieve views of the heart sufficient to calculate this index within 10 minutes of insertion of the probe.[ After completing the examination the clinician will report their findings into an App based survey. The primary timepoints will be whether the clinician could obtain the necessary views of the heart within 10 minutes of insertion. This data entry will be completed as soon after the procedure as patient stability allows (likely within 60 minutes).]

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 No limit(—)
性别
All

入选标准

  • Intubated major trauma patients presenting during the study periodAge 18 years and overPresenting directly from scene of injuryMeeting ‘shocked trauma’ callout criteria:- Systolic blood pressure (SBP) less than 90mmHg at any time- Shock index > 1 (Heart Rate/SBP)- Prehospital blood transfusion

排除标准

  • Not requiring intubation either prehospital or within 1 hour of arrival to the ED- Deceased on arrival- An Advanced Care Directive that precludes resuscitation

结局指标

主要结局

This is a feasibility study, assessing the clinicians ability to assess shock using the device. The primary outcome is the collapsibility index of the superior vena cava (two measurements of the maximum and minimum width of the SVC) as a validated marker of hypovolaemia. This will be reported as the proportion of patients where clinicians are able to achieve views of the heart sufficient to calculate this index within 10 minutes of insertion of the probe.[ After completing the examination the clinician will report their findings into an App based survey. The primary timepoints will be whether the clinician could obtain the necessary views of the heart within 10 minutes of insertion. This data entry will be completed as soon after the procedure as patient stability allows (likely within 60 minutes).]

次要结局

未报告次要终点

研究者

发起方
Associate Professor Christopher Groombridge

相似试验